×

Asymptotic behavior of a three-dimensional haptotactic cross-diffusion system modeling oncolytic virotherapy. (English) Zbl 1530.35126

The paper considers the problem \begin{align*} \begin{cases} u_t = \Delta u - \nabla \cdot (u \nabla v) + \mu u(1-u) - uz, \\ v_t = -(u+w) v, \\ w_t = \Delta w - \nabla \cdot (w \nabla v) - w + uz, \\ z_t = D_z \Delta z - z - uz + \beta w, \end{cases} \end{align*} complemented with initial and, for the PDEs, with no-flux boundary conditions, in smooth, bounded domains \(\Omega \subset \mathbb R^3\). Such a system arises in oncolytic virotherapy. More concretely, \(u\), \(v\), \(w\) and \(z\) denote (densities of) uninfected cancer cells, the extracellular matrix, infected cancer cells and the oncolytic virus, respectively. In contrast to several precedents, the paper under consideration accounts for haptotactic movement also of the infected cells, i.e., the term \(-\nabla \cdot (w \nabla v)\) is included in the system. (However, as it is often done in the literature, the authors neglect the remodelling term \(+\mu_v(1-v)\) of the extracellular matrix which is present in the model originally introduced in [T. Alzahrani et al., Math. Biosci. 310, 76–95 (2019; Zbl 1425.92103)].)
The main result states that if the initial data and \(\beta\) are suitably small (although the latter may be larger than \(1\)), then there exists a global classical solution which converges to the homogeneous equilibrium \((1, 0, 0, 0)\).
One key idea of the proof is to consider the largest interval \((0, T)\) in which \(\|z(\cdot, t)\|_{L^\infty(\Omega)} \le \sqrt{\varepsilon} \mathrm{e}^{-\delta t}\) (for suitably chosen \(\varepsilon\) and \(\delta\)). Working in \((0, T)\) then allows the authors to favourably apply the comparison principle for cooperative parabolic systems to certain transformed quantities of \(u\) and \(w\), which constitutes a key step towards showing that \(T = T_{\max}\) if \(T_{\max} < \infty\).

MSC:

35K55 Nonlinear parabolic equations
35B40 Asymptotic behavior of solutions to PDEs
35K57 Reaction-diffusion equations
35Q92 PDEs in connection with biology, chemistry and other natural sciences
92C17 Cell movement (chemotaxis, etc.)

Citations:

Zbl 1425.92103

References:

[1] Alzahrani, T., Eftimie, R. and Trucu, D., Multiscale modelling of cancer response to oncolytic viral therapy, Math. Bioci.310 (2019) 76-95. · Zbl 1425.92103
[2] Anderson, A. R., Chaplain, M. A. J., Newman, E. L., Steele, R. J. C. and Thompson, A. M., Mathematical modelling of tumor invasion and metastasis, J. Theor. Med.2 (2000) 129-154. · Zbl 0947.92012
[3] Anderson, A. R. and Chaplain, M. A. J., Continuous and discrete mathematical models of tumor induced angiogenesis, Bull. Math. Biol.60 (1998) 857-900. · Zbl 0923.92011
[4] Bellomo, N., Outada, N., Soler, J., Tao, Y. and Winkler, M., Chemotaxis and cross-diffusion models in complex environments: Models and analytic problems toward a multiscale vision, Math. Models Methods Appl. Sci.32 (2022) 713-792. · Zbl 1497.35039
[5] Bischoff, J. R.et al., An adenovirus mutant that replicates selectively in p53-deficient human tumor cells, Science274 (1996) 373-376.
[6] Chen, Z., Dampening effect of logistic source in a two-dimensional haptotaxis system with nonlinear zero-order interaction, J. Math. Anal. Appl.492 (2020) 124435. · Zbl 1462.35412
[7] Coffey, M. C., Strong, J. E., Forsyth, P. A. and Lee, P. W. K., Reovirus therapy of tumors with activated Ras pathways, Science282 (1998) 1332-1334.
[8] Dai, F. and Liu, B., A new result for global solvability of a two species cancer invasion haptotaxis model with tissue remodeling, SIAM J. Math. Anal.54 (2022) 1-35. · Zbl 1481.35252
[9] Fontelos, M. A., Friedman, A. and Hu, B., Mathematical analysis of a model for the initiation of angiogenesis, SIAM J. Math. Anal.33 (2002) 1330-1355. · Zbl 1020.35030
[10] Fukuhara, H., Ino, Y. and Todo, T., Oncolytic virus therapy: A new era of cancer treatment at dawn, Cancer Sci.107 (2016) 1373-1379.
[11] Ganly, I.et al., A phase I study of Onys-015, an E1B-attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer, Clinical Cancer Res.6 (2000) 798-806.
[12] Gujar, S., Pol, J. G., Kim, Y., Lee, P. W. and Kroemer, G., Antitumor benefits of antiviral immunity: An underappreciated aspect of oncolytic virotherapy, Trends Immunol.39 (2018) 209-221.
[13] Jin, C., Global classical solutions and convergence to a mathematical model for cancer cells invasion and metastatic spread, J. Differential Equations269 (2020) 3987-4021. · Zbl 1434.35257
[14] Jin, H. Y. and Xiang, T., Negligibility of haptotaxis effect in a chemotaxis-haptotaxis model, Math. Models Methods Appl. Sci.31 (2021) 1373-1417. · Zbl 1512.35118
[15] Li, Y. and Lankeit, J., Boundedness in a chemotaxis-haptotaxis model with nonlinear diffusion, Nonlinearity29 (2016) 1564-1595. · Zbl 1338.35438
[16] Li, J. and Wang, Y., Boundedness in a haptotactic cross-diffusion system modeling oncolytic virotherapy, J. Differential Equations270 (2021) 94-113. · Zbl 1452.35077
[17] Liţcanu, G. and Morales-Rodrigo, C., Asymptotic behavior of global solutions to a model of cell invasion, Math. Models Methods Appl. Sci.20 (2010) 1721-1758. · Zbl 1213.35250
[18] Liţcanu, G. and Morales-Rodrigo, C., Global solutions and asymptotic behavior for a parabolic degenerate coupled system arising from biology, Nonlinear Anal.72 (2010) 77-98. · Zbl 1230.35048
[19] Mondal, M., Guo, J., He, P. and Zhou, D., Recent advances of oncolytic virus in cancer therapy, Human Vaccines Immunotherap.16 (2020) 2389-2402.
[20] Nemunaitis, J.et al., Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: A phase II trial, Cancer Res.60 (2000) 6359-6366.
[21] Pang, P. Y. H. and Wang, Y., Global boundedness of solutions to a chemotaxis-haptotaxis model with tissue remodeling, Math. Models Methods Appl. Sci.28 (2018) 2211-2235. · Zbl 1416.35052
[22] Pang, P. Y. H. and Wang, Y., Asymptotic behavior of solutions to a tumor angiogenesis model with chemotaxis-haptotaxis, Math. Models Methods Appl. Sci.29 (2019) 1387-1412. · Zbl 1427.35295
[23] Ren, G. and Wei, J., Analysis of a two-dimensional triply haptotactic model with a fusogenic oncolytic virus and syncytia, Z. Angew. Math. Phys.4 (2021) 72, Aricle ID: 134. · Zbl 1466.35241
[24] Russell, S. J., Peng, K.-W. and Bell, J. C., Oncolytic virotherapy, Nat. Biotechnol.30 (2012) 658-670.
[25] Stinner, C., Surulescu, C. and Winkler, M., Global weak solutions in a PDE-ODE system modeling multiscale cancer cell invasion, SIAM J. Math. Anal.46 (2014) 1969-2007. · Zbl 1301.35189
[26] Tao, Y. and Winkler, M., Energy-type estimates and global solvability in a two-dimensional chemotaxis-haptotaxis model with remodeling of non-diffusible attractant, J. Differential Equations257 (2014) 784-815. · Zbl 1295.35144
[27] Tao, Y. and Winkler, M., Large time behavior in a multidimensional chemotaxis-haptotaxis model with slow signal diffusion, SIAM J. Math. Anal.47 (2015) 4229-4250. · Zbl 1328.35103
[28] Tao, Y. and Winkler, M., Global classical solutions to a doubly haptotactic cross-diffusion system modeling oncolytic virotherapy, J. Differential Equations268 (2020) 4973-4997. · Zbl 1430.35132
[29] Tao, Y. and Winkler, M., A critical virus production rate for blow-up suppression in a haptotaxis model for oncolytic virotherapy, Nonlinear Anal.198 (2020) 111870. · Zbl 1442.35480
[30] Tao, Y. and Winkler, M., Critical mass for infinite-time blow-up in a haptotaxis system with nonlinear zero-order interaction, Discrete Contin. Dyn. Syst. A41 (2021) 439-454. · Zbl 1458.35076
[31] Tao, Y. and Winkler, M., A critical virus production rate for efficiency of oncolytic virotherapy, Europ. J. Appl. Math.32 (2021) 301-316. · Zbl 1526.92012
[32] Tao, Y. and Winkler, M., Asymptotic stability of spatial homogeneity in a haptotaxis model for oncolytic virotherapy, Proc. Roy. Soc. Edinburgh Sect. A152 (2022) 81-101. · Zbl 1484.35363
[33] Tao, X. and Zhou, S., Dampening effects on global boundedness and asymptotic behavior in an oncolytic virotherapy model, J. Differential Equations308 (2022) 57-76. · Zbl 1479.35119
[34] Välä-Koskela, M. and Hinkkanen, A., Tumor restrictions to oncolytic virus, Biomedicines2 (2014) 163-194.
[35] Walker, C. and Webb, G. F., Global existence of classical solutions for a haptotaxis model, SIAM J. Math. Anal.38 (2007) 1694-1713. · Zbl 1120.92024
[36] Wang, Y. and Xu, C., Asymptotic behavior of a doubly haptotactic cross-diffusion model for oncolytic virotherapy, Proc. Roy. Soc. Edinburgh Sect. A153(3) (2023) 881-906. · Zbl 1518.35121
[37] Wei, Y., Wang, Y. and Li, J., Asymptotic behavior for solutions to an oncolytic virotherapy model involving triply haptotactic terms, Z. Angew. Math. Phys.6 (2022) 73, Article ID: 55. · Zbl 1485.35064
[38] Winkler, M., Aggregation vs. Global diffusive behavior in the higher-dimensional Keller-Segel model, J. Differential Equations12 (2010) 2889-2905. · Zbl 1190.92004
[39] Wong, H., Lemoine, N. and Wang, Y., Oncolytic viruses for cancer therapy: Overcoming the obstacles, Viruses2 (2010) 79-106.
[40] Zheng, J. and Ke, Y., Large time behavior of solutions to a fully parabolic chemotaxis-haptotaxis model in \(N\) dimensions, J. Differential Equations266 (2019) 1969-2018. · Zbl 1416.92031
[41] Zhigun, A., Surulescu, C. and Uatay, A., Global existence for a degenerate haptotaxis model of cancer invasion, Z. Angew. Math. Phys.6 (2016) 67, Article ID: 136. · Zbl 1359.35205
This reference list is based on information provided by the publisher or from digital mathematics libraries. Its items are heuristically matched to zbMATH identifiers and may contain data conversion errors. In some cases that data have been complemented/enhanced by data from zbMATH Open. This attempts to reflect the references listed in the original paper as accurately as possible without claiming completeness or a perfect matching.